Literature DB >> 15225174

Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn.

M Frazzoni1, E De Micheli, P Zentilin, V Savarino.   

Abstract

BACKGROUND: Patients with endoscopy-negative heartburn can be subdivided into non-erosive reflux disease and functional heartburn on the basis of abnormal and normal, respectively, oesophageal acid exposure. Different pathophysiological characteristics could explain the reportedly low efficacy of proton pump inhibitors in functional heartburn. AIM: To assess if non-erosive reflux disease and functional heartburn are pathophysiologically distinguishable.
METHODS: Oesophageal manometry and pH-monitoring were performed in 145 patients with endoscopy-negative heartburn, in 72 patients with erosive reflux disease, in 58 patients with complicated reflux disease, and in 60 controls.
RESULTS: Patients with non-erosive reflux disease (84 cases) and functional heartburn (61 cases) differed with regard to the prevalence of hiatal hernia (49% vs. 31%, P = 0.008), the mean lower oesophageal sphincter tone (18.5 vs. 28.4 mmHg, P < 0.05), and the number of upright diurnal acid refluxes lasting more than 5 min (3.6 vs. 0.37, P < 0.05). The results were very close in thenon-erosive reflux disease, erosive reflux disease and complicated reflux disease groups, whilst patients with functional heartburn were indistinguishable from controls.
CONCLUSIONS: Pathophysiological characteristics typical of gastro-oesophageal reflux disease are found in patients with non-erosive reflux disease but not in patients with functional heartburn. This could explain the reportedly low efficacy of proton pump inhibitors in functional heartburn and suggests considering different management strategies.

Entities:  

Mesh:

Year:  2004        PMID: 15225174     DOI: 10.1111/j.1365-2036.2004.01998.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  19 in total

Review 1.  Diagnosis and Management of Functional Heartburn.

Authors:  Christine Hachem; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

2.  Functional heartburn.

Authors:  Ram Dickman; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

Review 3.  Esophageal Impedance Monitoring: Clinical Pearls and Pitfalls.

Authors:  Karthik Ravi; David A Katzka
Journal:  Am J Gastroenterol       Date:  2016-06-21       Impact factor: 10.864

Review 4.  Esophageal motility abnormalities in gastroesophageal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Maria Giacchino; Giorgia Bodini; Elisa Marabotto; Santino Marchi; Vincenzo Savarino; Edoardo Savarino
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

Review 5.  Laparoscopic fundoplication for gastroesophageal reflux disease.

Authors:  Marzio Frazzoni; Micaela Piccoli; Rita Conigliaro; Leonardo Frazzoni; Gianluigi Melotti
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

6.  Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis.

Authors:  Yao-Chun Hsu; Tzeng-Huey Yang; Wei-Lun Hsu; Huei-Tang Wu; Yang-Chih Cheng; Ming-Feng Chiang; Chaur-Shine Wang; Hwai-Jeng Lin
Journal:  Br J Clin Pharmacol       Date:  2010-08       Impact factor: 4.335

7.  Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions--a debate: pro.

Authors:  Tomás Navarro-Rodriguez; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

8.  Therapeutic effects of laparoscopic fundoplication for nonerosive gastroesophageal reflux disease.

Authors:  Nobuo Omura; Hideyuki Kashiwagi; Fumiaki Yano; Kazuto Tsuboi; Yoshio Ishibashi; Naruo Kawasaki; Yutaka Suzuki; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

Review 9.  Nonerosive reflux disease: a pathophysiologic perspective.

Authors:  John D Long; Roy C Orlando
Journal:  Curr Gastroenterol Rep       Date:  2008-06

Review 10.  Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure.

Authors:  Ronnie Fass
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.